blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3408406

EP3408406 - A NOVEL Y-SHAPED ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE [Right-click to bookmark this link]
Former [2018/49]A NOVEL ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE
[2022/09]
StatusNo opposition filed within time limit
Status updated on  21.04.2023
Database last updated on 04.11.2024
FormerThe patent has been granted
Status updated on  13.05.2022
FormerGrant of patent is intended
Status updated on  07.02.2022
FormerExamination is in progress
Status updated on  03.07.2020
FormerRequest for examination was made
Status updated on  02.11.2018
FormerThe international publication has been made
Status updated on  04.08.2017
Formerunknown
Status updated on  03.02.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): MC		published on 17.07.2024  [2024/29]
Applicant(s)For:AL  AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  RS  SE  SI  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diagnostics GmbH
Sandhofer Straße 116
68305 Mannheim / DE
[2018/49]
Inventor(s)01 / KLASS, Daniel
Lake Bluff, Illinois 60044 / US
 [2022/24]
Former [2018/49]01 / KLASS, Daniel
422 Pismo Ct.
Livermore, CA 94550 / US
Representative(s)Burger, Alexander, et al
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[2022/24]
Former [2018/49]Burger, Alexander, et al
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date17701499.026.01.2017
[2018/49]
WO2017EP51588
Priority number, dateUS201662288903P29.01.2016         Original published format: US 201662288903 P
[2018/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017129647
Date:03.08.2017
Language:EN
[2017/31]
Type: A1 Application with search report 
No.:EP3408406
Date:05.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 03.08.2017 takes the place of the publication of the European patent application.
[2018/49]
Type: B1 Patent specification 
No.:EP3408406
Date:15.06.2022
Language:EN
[2022/24]
Search report(s)International search report - published on:EP03.08.2017
ClassificationIPC:C12Q1/6806, C12Q1/6855, C12Q1/6869
[2022/09]
CPC:
C12Q1/6869 (EP,US); C12N15/1065 (US); C12Q1/6806 (EP,US);
C12Q1/6855 (EP,US)
C-Set:
C12Q1/6806, C12Q2525/155, C12Q2525/191, C12Q2535/119, C12Q2535/122, C12Q2563/179 (US,EP);
C12Q1/6855, C12Q2525/155, C12Q2535/119, C12Q2535/122, C12Q2563/179, C12Q2565/514 (US,EP);
C12Q1/6869, C12Q2525/155, C12Q2525/191, C12Q2535/119, C12Q2563/179 (EP,US)
Former IPC [2018/49]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/49]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUARTIGER Y-FÖRMIGER ADAPTER ZUR NUKLEINSÄURESEQUENZIERUNG UND VERFAHREN ZUR VERWENDUNG[2022/09]
English:A NOVEL Y-SHAPED ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE[2022/09]
French:NOUVEL ADAPTATEUR DU TYP Y DE SÉQUENÇAGE D'ACIDES NUCLÉIQUES ET PROCÉDÉ D'UTILISATION[2022/09]
Former [2018/49]NEUARTIGER ADAPTER ZUR NUKLEINSÄURESEQUENZIERUNG UND VERFAHREN ZUR VERWENDUNG
Former [2018/49]A NOVEL ADAPTOR FOR NUCLEIC ACID SEQUENCING AND METHOD OF USE
Former [2018/49]NOUVEL ADAPTATEUR DE SÉQUENÇAGE D'ACIDES NUCLÉIQUES ET PROCÉDÉ D'UTILISATION
Entry into regional phase29.08.2018National basic fee paid 
29.08.2018Designation fee(s) paid 
29.08.2018Examination fee paid 
Examination procedure29.08.2018Examination requested  [2018/49]
29.08.2018Date on which the examining division has become responsible
05.03.2019Amendment by applicant (claims and/or description)
07.07.2020Despatch of a communication from the examining division (Time limit: M02)
16.09.2020Reply to a communication from the examining division
21.12.2020Despatch of a communication from the examining division (Time limit: M06)
17.06.2021Reply to a communication from the examining division
08.02.2022Communication of intention to grant the patent
06.05.2022Fee for grant paid
06.05.2022Fee for publishing/printing paid
06.05.2022Receipt of the translation of the claim(s)
Opposition(s)16.03.2023No opposition filed within time limit [2023/21]
Fees paidRenewal fee
09.01.2019Renewal fee patent year 03
10.01.2020Renewal fee patent year 04
12.01.2021Renewal fee patent year 05
13.01.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
MC15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SI15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
IE26.01.2023
LU26.01.2023
BE31.01.2023
[2024/29]
Former [2024/08]AL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SI15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
IE26.01.2023
LU26.01.2023
BE31.01.2023
Former [2023/49]AL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SI15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
LU26.01.2023
BE31.01.2023
Former [2023/43]AL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SI15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
LU26.01.2023
Former [2023/25]AL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SI15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
Former [2023/21]AL15.06.2022
AT15.06.2022
CZ15.06.2022
DK15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
Former [2023/17]AL15.06.2022
AT15.06.2022
CZ15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
Former [2023/12]AT15.06.2022
CZ15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
IS15.10.2022
PT17.10.2022
Former [2023/11]AT15.06.2022
CZ15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
PL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
PT17.10.2022
Former [2023/09]AT15.06.2022
CZ15.06.2022
EE15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
RO15.06.2022
RS15.06.2022
SE15.06.2022
SK15.06.2022
SM15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
PT17.10.2022
Former [2023/07]AT15.06.2022
FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
RS15.06.2022
SE15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
Former [2023/02]FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
NL15.06.2022
RS15.06.2022
SE15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
Former [2022/50]FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
RS15.06.2022
SE15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
Former [2022/49]FI15.06.2022
HR15.06.2022
LT15.06.2022
LV15.06.2022
SE15.06.2022
BG15.09.2022
NO15.09.2022
GR16.09.2022
Former [2022/47]FI15.06.2022
LT15.06.2022
SE15.06.2022
NO15.09.2022
Cited inInternational search[A]WO2009133466  (POPULATION GENETICS TECHNOLOGI [GB], et al) [A] 1-15 * figures 4,5 *;
 [X]US2013034546  (RAVA RICHARD P [US], et al) [X] 1-3,8,9,15 * paragraphs [0719] - [0720] *;
 [XI]WO2013181170  (UNIV TEXAS [US]) [X] 1-3,7,10-13,15 * paragraphs [0504] - [0506] - [ 515] - [0523]; figures 2-1, 2-2 * [I] 8,9;
 [XI]WO2015100427  (GUARDANT HEALTH INC [US]) [X] 1-4,8-15 * paragraphs [0133] - [0135] - [0137] , [ 141] , [0173] , [0257] , [ 280] - [0281]; claim 19 * [I] 5-7;
 [XPI]WO2016040901  (UNIV LELAND STANFORD JUNIOR [US]) [XP] 1-3,6 * paragraphs [0076] , [0199]; figures 1,6B * [I] 4,7-15;
 [XP]WO2016176091  (ILLUMINA INC [US]) [XP] 1-3,7-15* figure 2 *
by applicantUS6395887
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.